4//SEC Filing
Daws D. Ryan 4
Accession 0000929638-23-003339
CIK 0001980845other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 5:52 PM ET
Size
5.0 KB
Accession
0000929638-23-003339
Insider Transaction Report
Form 4
Daws D. Ryan
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-11-30+232,000→ 232,000 totalExercise: $7.66Exp: 2033-11-30→ Common Shares (232,000 underlying)
Footnotes (1)
- [F1]This option vests at 25% on the first anniversary of the grant date, with the remaining portion to vest monthly over the remaining three years.
Documents
Issuer
enGene Holdings Inc.
CIK 0001980845
Entity typeother
Related Parties
1- filerCIK 0001598602
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 5:52 PM ET
- Size
- 5.0 KB